Skip to main content
TLSA logo
TLSA
(NASDAQ)
Tiziana Life Sciences Ltd
$1.25-- (--)
Loading... - Market loading

Tiziana Life Sciences (TLSA) Key Statistics & Financial Metrics

Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.

Stock Valuation Metrics

Market value, earnings multiples, and pricing ratios

Market Valuation & Earnings Multiples

Market capitalization, P/E ratios, and enterprise value

Market Cap73.02M
Enterprise Value65.87M

Price-Based Ratios

Valuation ratios based on stock price

Price/Book (mrq)7.94
Price/Tangible Book (mrq)7.94

Enterprise Value Ratios

EV-based valuation multiples

EV/Earnings-2.11
EV/EBITDA-1.70
EV/EBIT-3.94
EV/FCF-5.74

Stock Price

Current price, 52-week range, and moving averages

Current Price$1.25
1-Day Change6.84%
52-Week High$2.60
52-Week Low$0.73
52-Week Change17.92%
YTD Change-21.88%
1-Year Change12.61%
50-Day MA$1.39
200-Day MA$1.69
Avg Volume (30 day)111.08K

Share Statistics

Outstanding shares, float, and per-share metrics

Shares Outstanding58.41M
Book Value per Share$0.16
Net Cash per Share$0.12
FCF per Share$-0.20

Profitability & Financial Performance

Profit margins, return metrics, and earnings analysis

Profit Margins

Profitability margins across income statement

Return on Investment Metrics

ROE, ROA, ROIC, and capital efficiency ratios

Return on Equity (ttm)-339.38%
Return on Assets (ttm)-188.12%
Return on Invested Capital (ttm)-643.22%
Return on Capital Employed (ttm)-181.96%

Income Statement (TTM)

Trailing twelve months revenue and earnings

Revenue0.00
Gross Profit-316.00K
Operating Income-37.27M
Pretax Income-38.98M
Net Income-31.22M
EBITDA-38.66M
EBIT-16.74M
Diluted EPS$-0.53

Cash Flow (TTM)

Operating cash flow and free cash flow metrics

Operating Cash Flow-11.45M
Capital Expenditures21.05K
Free Cash Flow-11.47M

Growth Rates (YoY)

Year-over-year growth metrics

Financial Health & Dividends

Balance sheet analysis, debt ratios, and dividend metrics

Assets & Cash

Total assets and cash positions

Total Assets (mrq)16.60M
Cash & Securities (mrq)7.25M
Net Cash (mrq)7.14M
Net Cash per Share$0.12

Debt & Liabilities

Liabilities, debt, equity, and working capital

Total Debt (mrq)107.00K
Working Capital (mrq)5.32M
Total Equity (mrq)9.20M
Book Value per Share$0.16

Liquidity & Leverage

Liquidity, leverage, and debt coverage ratios

Current Ratio (mrq)1.72
Quick Ratio (mrq)1.72
Debt/Equity (mrq)0.01

Dividend History & Payout Analysis

Dividend yield, payout ratios, and growth metrics

Dividend per Share (TTM)$0.00
Dividend Yield0.00%

Yield Metrics

Earnings, FCF, buyback, and shareholder yields

Earnings Yield-42.76%
FCF Yield-15.72%
Buyback Yield0.00%
Total Shareholder Yield0.00%

Financial Health Scores

Risk assessment and quality metrics

Altman Z-Score0.30
Piotroski F-Score3/9

Frequently Asked Questions About Tiziana Life Sciences Statistics

What are the key financial metrics for TLSA?

Tiziana Life Sciences Ltd (TLSA) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.

What is TLSA's valuation analysis?

The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Tiziana Life Sciences is overvalued or undervalued.

How do I read TLSA's profitability ratios?

Tiziana Life Sciences's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.

What do TLSA's debt ratios indicate?

The financial health section shows Tiziana Life Sciences's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.

What is TLSA's dividend analysis?

The dividend section covers Tiziana Life Sciences's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.